List of Epinephrine In 0.9 Percent Sodium Chloride drug patents
Epinephrine In 0.9 Percent Sodium Chloride is owned by Par Sterile Products.
Epinephrine In 0.9 Percent Sodium Chloride contains Epinephrine.
Epinephrine In 0.9 Percent Sodium Chloride has a total of 3 drug patents out of which 0 drug patents have expired.
Epinephrine In 0.9 Percent Sodium Chloride was authorised for market use on 21 April, 2023.
Epinephrine In 0.9 Percent Sodium Chloride is available in solution;intravenous dosage forms.
Epinephrine In 0.9 Percent Sodium Chloride can be used as to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.
The generics of Epinephrine In 0.9 Percent Sodium Chloride are possible to be released after 21 March, 2039.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11083698 | PAR STERILE PRODUCTS | Epinephrine compositions and containers |
Mar, 2039
(15 years from now) | |
| US11207280 | PAR STERILE PRODUCTS | Epinephrine compositions and containers |
Mar, 2039
(15 years from now) | |
| US10653646 | PAR STERILE PRODUCTS | Epinephrine compositions and containers |
Mar, 2039
(15 years from now) | |
Drugs and Companies using EPINEPHRINE ingredient
Market Authorisation Date: 21 April, 2023
Treatment: To increase mean arterial blood pressure in adult patients with hypotension associated with septic shock
Dosage: SOLUTION;INTRAVENOUS
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic